Page 28 - GALENIKA MEDICAL JOURNAL
P. 28

češće kod muškog pola. Na značaj hemoptizija ukazuje i podatak da oko jedne četvrtine pacijenata
          zahtijeva hitno bolničko liječenje. Bronhološko ispitivanje u cilju dijagnostike, zaustavljanja
          krvarenja ili liječenja je neophodno kod oko trećine pacijenata sa hemoptizijama. Pravovremena i
          adekvatna dijagnostika, u cilju promptnog preduzimanja mjera liječenja, je ključna kod pacijenata sa
          hemoptizijama jer iskašljavanje krvi može biti životno ugrožavajuće i dovesti do fatalnog ishoda.




          Abstract

          Introduction: Hemoptysis is the expectoration of blood from the tracheobronchial tree. Hemoptysis is the most common
          manifestation of pulmonary or extrapulmonary diseases. The amount of blood coughed up can be minimal to massive,
          which can be life-threatening. This research aims to determine the etiology and diagnostics of hemoptysis.


          Materials and methods: This retrospective study included 150 patients with hemoptysis who were examined in the
          Emergency Center in April 2022. and April 2023.

          Results: In the study group, about 2/3 of the patients had at least one comorbidity, and the most common was arterial
          hypertension. It was also the main cause of hemoptysis (41%). Approximately half of the patients had a pulmonary or
          extra-pulmonary cause. A quarter of patients needed hospital treatment. 31 bronchoscopies and 2 embolizations were
          performed. There was no statistically significant association between elevated D-dimer values   and CT findings of pulmonary
          embolism.

          Conclusion: Coughing up blood can be life-threatening and lead to a fatal outcome. That is why timely and adequate
          diagnostics are needed. Although patients are most often referred to a pulmonologist, the reason is also extra-pulmonary,
          and a multidisciplinary approach is needed to provide adequate care and timely treatment.

          Keywords: hemoptysis, bronchoscopy, comorbidity, embolization





          Literatura                                         10.  Moua J, Nussbaum E, Liao E, Randhawa IS. Beta-blocker management
                                                                of refractory hemoptysis in cystic fibrosis: a novel treatment approach.
                                                                Ther Adv Respir Dis. 2013 Aug;7(4):217-23.
          1.  Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ,   11.  Zheng Z, Zhuang Z, Yang M, Luo J, Zhang W, Yan Z, et al. Bronchial
             Herráez Ortega I, Jiménez Merchán R. Diagnosis and Treatment of   artery embolization for hemoptysis: A systematic review and meta-
             Hemoptysis. Arch Bronconeumol. 2016 Jul;52(7):368-77.  analysis. J Interv Med. 2021 Aug 13;4(4):172-80.
          2.  Abdulmalak C, Cottenet J, Beltramo G, Georges M, Camus P, Bonniaud P,   12.  Latimer KM. Lung Cancer: Clinical Presentation and Diagnosis. FP
             et al. Haemoptysis in adults: a 5-year study using the French nationwide   Essent. 2018 Jan;464:23-26.
             hospital administrative database. Eur Respir J. 2015 Aug;46(2):503-11.
                                                             13.  An J, Nam Y, Cho H, Chang J, Kim DK, Lee KS. Acute Pulmonary
          3.  Singhal M, Lal A, Prabhakar N, Yadav MK, Vijayvergiya R, Behra D, et al.   Embolism and Chronic Thromboembolic Pulmonary Hypertension:
             Non-bronchial causes of haemoptysis: imaging and interventions. Pol J   Clinical and Serial CT Pulmonary Angiographic Features. J Korean Med
             Radiol. 2020 Jun 30;85:e328-e339.                  Sci. 2022 Mar 14;37(10):e76.
          4.  Marquis KM, Raptis CA, Rajput MZ, Steinbrecher KL, Henry TS, Rossi   14.  Deshwal H, Sinha A, Mehta AC. Life-Threatening Hemoptysis. Semin
             SE, et al. CT for Evaluation of Hemoptysis. Radiographics. 2021 May-  Respir Crit Care Med. 2021 Feb;42(1):145-59.
             Jun;41(3):742-61.
          5.  Davidson K, Shojaee S. Managing Massive Hemoptysis. Chest. 2020
             Jan;157(1):77-88.                                  Konflikt interesa: Nema
          6.  Earwood JS, Thompson TD. Hemoptysis: evaluation and management.
             Am Fam Physician. 2015 Feb 15;91(4):243-9.         Primljeno: 13. 02. 2024.
                                                                Prihvaćeno: 06. 03. 2024.
          7.  Park JE, Seo JA, Cha JG, Lim JK, Park J, Lee YH, et al. Association between
             High Blood Pressure in the Emergency Department and Cryptogenic   Onlajn: 01. 06. 2024.
             Hemoptysis. J Clin Med. 2022 Sep 8;11(18):5302.
          8.  Ittrich H, Bockhorn M, Klose H, Simon M. The Diagnosis and Treatment
             of Hemoptysis. Dtsch Arztebl Int. 2017 Jun 5;114(21):371-81.
          9.  Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. ESC
             Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis
             and treatment of pulmonary hypertension: The Joint Task Force for
             the Diagnosis and Treatment of Pulmonary Hypertension of the
             European Society of Cardiology (ESC) and the European Respiratory
             Society (ERS): Endorsed by: Association for European Paediatric and
             Congenital Cardiology (AEPC), International Society for Heart and Lung
             Transplantation (ISHLT). Eur Heart J. 2016 Jan 1;37(1):67-119.


          26     DOI: 10.5937/Galmed2410014J
   23   24   25   26   27   28   29   30   31   32   33